Latest Breaking News On - Medical officer merdad parsey - Page 1 : comparemela.com

Gilead writes $2.4B off Trodelvy as CEO underscores focus

Gilead writes $2.4B off Trodelvy as CEO underscores focus
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesTennesseeAmericanJohanna mercierMerdad parseyAndrew dickinsonMerck keytrudaDaiichi sankyoAstrazenecaGilead sciencesEuropean medicines agencyAmerican society of clinical oncologyAmerican societyClinical oncologyMedical officer merdad parseyTennessee oncology

GILD Stock Slips As Earnings, Guidance Lag But Covid Drives Sales Beat

GILD Stock Slips As Earnings, Guidance Lag But Covid Drives Sales Beat
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Andrew dickinsonMerdad parseyJohanna mercierGilead sciencesBusiness dailyExecutive danielo dayMedical officer merdad parsey

Gilead sinks after lung cancer drug fails to improve survival

Gilead sinks after lung cancer drug fails to improve survival
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLondonCity ofUnited kingdomFoster cityCaliforniaDaiichi sankyoMerdad parseyAstrazenecaMerck coDaiichi sankyo coAbbvie incAmbrx biopharma incJohnsonGilead sciences inc

Gilead Sinks After Lung Cancer Drug Fails to Improve Survival

(Bloomberg) Gilead Sciences Inc.’s Trodelvy failed to significantly improve survival in a trial of patients with advanced lung cancer, a blow to the targeted treatment that’s in one of the most promising classes in oncology.Most Read from BloombergFlorida Governor DeSantis Drops Out of 2024 Race, Endorses TrumpHong Kong Stocks at 36% Discount Show True Depth of China GloomMorgan Stanley, JPMorgan Say Buy the Dip After Treasury RoutGloom Over China Assets Is Spreading Beyond Battered StocksHed

LondonCity ofUnited kingdomCaliforniaUnited statesNew yorkFoster cityMerdad parseyDaiichi sankyoBloomberg businessweekMerck coDaiichi sankyo coAbbvie incImmunogen incAstrazenecaAmbrx biopharma inc

Gilead Quarterly Profit Falls on COVID Sales Drop

Gilead Sciences reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset another strong performance by HIV drugs.

CaliforniaUnited statesMerdad parseyDeena beasleyGilead sciences onReutersMedical officer merdad parseyWall streetReporting by michael ermanBill berkrotPractice managementRevenueCovid 19019 novel coronavirus019 ncovUhan coronavirus